Matt Kushner, PhD

Professor, Department of Psychiatry and Behavioral Sciences

Matt Kushner

Contact Info

kushn001@umn.edu

Office Phone 612-273-9806

Fax 612-273-9774

Office Address:
Department of Psychiatry & Behavioral Sciences
F282/2A West-B
8393A (Campus Delivery Code)
2450 Riverside Ave
Minneapolis, MN 55454

Mailing Address:
Department of Psychiatry & Behavioral Sciences
F282/2A West-B
8393A (Campus Delivery Code)
2450 Riverside Ave
Minneapolis, MN 55454

Administrative Assistant Name
Teneshia Collins

Administrative Email
coll1148@umn.edu

PhD, Clinical Psychology, University of Missouri-Columbia, 1991

BA, Psychology and Philosophy, University of Nebraska-Lincoln, 1983

Internship, Psychology, Medical College of Pennsylvania, 1990 - 1991

Summary

I received my BA in Psychology from the University of Nebraska, graduating Magna Cum Laude. I completed my PhD in Clinical Psychology from the University of Missouri, and my Clinical Psychology Internship from the Eastern Pennsylvania Psychiatric Institute.

I am a Professor of Psychiatry who studies the association of addiction and comorbid psychiatric disorders. My current research, funded by NIAAA, focuses on developing and testing cognitive behavioral treatments that can improve the alcohol use disorder treatment outcomes for individuals with co-occurring anxiety and depressive disorders. My research has also explored the epidemiology, causes, course and treatment of co-occurring disorders ("comorbidity"). To date, I have 88 publications, 4470 citations, and an h-index of 35.

I am the Program Director of P3, an intensive 10-session grant writing program for Assistant Professors in the University's Medical School. I am the Program Director of the NIDA T32 Postdoctoral Training Program focused on Comorbidity between Substance Abuse and Mental Illness. I am also Director of the Cognitive-Behavioral Anxiety Disorders Clinic.

Expertise

  • Association of alcohol use disorders with co-occurring anxiety disorders.

Awards & Recognition

External Sources

  • Dan Anderson Award (recognizes a single publication with high clinical impact) 2013
  • Distinguished Alumnus, University of Missouri Psychology 2009
  • Distinguished Scholar, Minnesota Psychological Association 2008

Professional Associations

  • Research Society on Alcoholism
  • Association for Behavioral and Cognitive Therapies

Research

Research Summary/Interests

Internalizing psychopathology (anxiety disorders and depressive disorders) co-occurring with substance abuse disorders (especially alcohol dependence). My research has explored the, epidemiology, causes, course and treatment of co-occurring disorders ("comorbidity").

Publications

1. Anker JJ, Forbes MK, Almquist ZW, Menk JS, Thuras P, Unruh AS, Kushner MG. A network approach to modeling comorbid internalizing and alcohol use disorders. J Abnorm Psychol. 2017;126(3):325-39. Epub 2017/02/10. doi: 10.1037/abn0000257. PubMed PMID: 28182444; PMCID: PMC5388354.

2. Mataix-Cols D, Fernandez de la Cruz L, Monzani B, Rosenfield D, Andersson E, Perez-Vigil A, Frumento P, de Kleine RA, Difede J, Dunlop BW, Farrell LJ, Geller D, Gerardi M, Guastella AJ, Hofmann SG, Hendriks GJ, Kushner MG, Lee FS, Lenze EJ, Levinson CA, McConnell H, Otto MW, Plag J, Pollack MH, Ressler KJ, Rodebaugh TL, Rothbaum BO, Scheeringa MS, Siewert-Siegmund A, Smits JAJ, Storch EA, Strohle A, Tart CD, Tolin DF, van Minnen A, Waters AM, Weems CF, Wilhelm S, Wyka K, Davis M, Ruck C, and the DCSAC, Altemus M, Anderson P, Cukor J, Finck C, Geffken GR, Golfels F, Goodman WK, Gutner C, Heyman I, Jovanovic T, Lewin AB, McNamara JP, Murphy TK, Norrholm S, Thuras P. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data. JAMA Psychiatry. 2017;74(5):501-10. Epub 2017/01/26. doi: 10.1001/jamapsychiatry.2016.3955. PubMed PMID: 28122091.

3. Anker JJ, Kushner MG, Thuras P, Menk J, Unruh AS. Drinking to cope with negative emotions moderates alcohol use disorder treatment response in patients with co-occurring anxiety disorder. Drug Alcohol Depend. 2016;159:93-100. Epub 2016/01/01. doi: 10.1016/j.drugalcdep.2015.11.031. PubMed PMID: 26718394; PMCID: PMC4782758.

4. Kim SW, Kushner MG, Yoon G, Anker J, Grant JE. Low-Dose d-Cycloserine for Depression? J Clin Psychiatry. 2016;77(8):e1007. Epub 2016/08/26. doi: 10.4088/JCP.15lr10272. PubMed PMID: 27561144.

5. Kushner MG. Seventy-five years of comorbidity research. J Stud Alcohol Drugs Suppl. 2014;75 Suppl 17:50-8. Epub 2014/02/26. PubMed PMID: 24565311; PMCID: PMC4453502.

6. Verges A, Kushner MG, Jackson KM, Bucholz KK, Trull TJ, Lane SP, Sher KJ. Personality disorders and the persistence of anxiety disorders: evidence of a time-of-measurement effect in NESARC. J Anxiety Disord. 2014;28(2):178-86. Epub 2013/11/12. doi: 10.1016/j.janxdis.2013.09.012. PubMed PMID: 24211148; PMCID: PMC3943573.

7. Book SW, Thomas SE, Smith JP, Randall PK, Kushner MG, Bernstein GA, Specker SM, Miller PM, Randall CL. Treating individuals with social anxiety disorder and at-risk drinking: phasing in a brief alcohol intervention following paroxetine. J Anxiety Disord. 2013;27(2):252-8. Epub 2013/03/26. doi: 10.1016/j.janxdis.2013.02.008. PubMed PMID: 23523988; PMCID: PMC3756669. January 2020

8. Kushner MG, Krueger RF, Wall MM, Maurer EW, Menk JS, Menary KR. Modeling and treating internalizing psychopathology in a clinical trial: a latent variable structural equation modeling approach. Psychol Med. 2013;43(8):1611-23. Epub 2013/01/10. doi: 10.1017/S0033291712002772. PubMed PMID: 23298776; PMCID: PMC3759231.

9. Kushner MG, Maurer EW, Thuras P, Donahue C, Frye B, Menary KR, Hobbs J, Haeny AM, Van Demark J. Hybrid cognitive behavioral therapy versus relaxation training for co-occurring anxiety and alcohol disorder: a randomized clinical trial. J Consult Clin Psychol. 2013;81(3):429-42. Epub 2013/01/02. doi: 10.1037/a0031301. PubMed PMID: 23276124; PMCID: PMC3756682.

10. Grant JE, Mooney ME, Kushner MG. Prevalence, correlates, and comorbidity of DSM-IV obsessive-compulsive personality disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Psychiatr Res. 2012;46(4):469-75. Epub 2012/01/20. doi: 10.1016/j.jpsychires.2012.01.009. PubMed PMID: 22257387. 

Teaching

Teaching Areas

Dr. Kushner is the Program Director of P3, an intensive 10-session grant writing program for Assistant Professors in the University's Medical School. He is also the Program Director of the NIDA T32 Post-Doctoral Training Program focused on Comorbidity between Substance Abuse and Mental Illness. 

Clinical

Clinical Interests

Behavioral and cognitive therapies for anxiety disorders, especially obsessive compulsive disorder